Skip to main content
Journal cover image

Current immunotherapeutic strategies in colon cancer.

Publication ,  Journal Article
Morse, M; Langer, L; Starodub, A; Hobeika, A; Clay, T; Lyerly, HK
Published in: Surg Oncol Clin N Am
October 2007

Because chemotherapy is standard in the treatment of colorectal cancer, it is important to demonstrate whether immunizations may be given to patients receiving systemic chemotherapy. Although some studies have demonstrated immune responses in patients with metastatic colorectal carcinoma who failed standard chemotherapy, the setting of minimal residual disease may be the preferred setting for cancer vaccines. It may be important to choose antigens that have functions important to the cancer cell. The best adjuvant is not well established and may depend on the type of immune response desired. The immune system is "programmed" to down-regulate immune responses once they have become activated to avoid the development of autoimmune disease.

Duke Scholars

Published In

Surg Oncol Clin N Am

DOI

ISSN

1055-3207

Publication Date

October 2007

Volume

16

Issue

4

Start / End Page

873 / x

Location

United States

Related Subject Headings

  • Vaccination
  • Rectal Neoplasms
  • Oncology & Carcinogenesis
  • Immunotherapy
  • Humans
  • Colorectal Neoplasms
  • Colonic Neoplasms
  • Cancer Vaccines
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Morse, M., Langer, L., Starodub, A., Hobeika, A., Clay, T., & Lyerly, H. K. (2007). Current immunotherapeutic strategies in colon cancer. Surg Oncol Clin N Am, 16(4), 873–x. https://doi.org/10.1016/j.soc.2007.07.005
Morse, Michael, Lee Langer, Alexander Starodub, Amy Hobeika, Timothy Clay, and H Kim Lyerly. “Current immunotherapeutic strategies in colon cancer.Surg Oncol Clin N Am 16, no. 4 (October 2007): 873–x. https://doi.org/10.1016/j.soc.2007.07.005.
Morse M, Langer L, Starodub A, Hobeika A, Clay T, Lyerly HK. Current immunotherapeutic strategies in colon cancer. Surg Oncol Clin N Am. 2007 Oct;16(4):873–x.
Morse, Michael, et al. “Current immunotherapeutic strategies in colon cancer.Surg Oncol Clin N Am, vol. 16, no. 4, Oct. 2007, pp. 873–x. Pubmed, doi:10.1016/j.soc.2007.07.005.
Morse M, Langer L, Starodub A, Hobeika A, Clay T, Lyerly HK. Current immunotherapeutic strategies in colon cancer. Surg Oncol Clin N Am. 2007 Oct;16(4):873–x.
Journal cover image

Published In

Surg Oncol Clin N Am

DOI

ISSN

1055-3207

Publication Date

October 2007

Volume

16

Issue

4

Start / End Page

873 / x

Location

United States

Related Subject Headings

  • Vaccination
  • Rectal Neoplasms
  • Oncology & Carcinogenesis
  • Immunotherapy
  • Humans
  • Colorectal Neoplasms
  • Colonic Neoplasms
  • Cancer Vaccines
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis